Skin substitutes based on allogenic fibroblasts or keratinocytes for chronic wounds not responding to conventional therapy: a retrospective observational study

A review of the current research on the role of bFGF and VEGF in angiogenesis

(2014) M. Przybylski   Journal of Wound Care

The role of skin substitutes in the management of chronic cutaneous wounds

(2013) Nicholas S. Greaves et al.   WOUND REPAIR AND REGENERATION

Acceleration of diabetic wound healing by collagen-binding vascular endothelial growth factor in diabetic rat model

(2010) Xin Yan et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute

(2010) Naoki Ohara et al.   JOURNAL OF ARTIFICIAL ORGANS

Management of Acute Wounds

(2009) Charles K. Lee et al.   SURGICAL CLINICS OF NORTH AMERICA

Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute

(2008) Naoto Yamada et al.   JOURNAL OF ARTIFICIAL ORGANS

Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-β, and IL-8

(2008) Akiko Hashimoto et al.   JOURNAL OF ARTIFICIAL ORGANS

Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg

(2008) Naoto Yamada et al.   JOURNAL OF ARTIFICIAL ORGANS

Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers

(2007) Eduardo Anitua et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS